Sandeep Bhosale

Dr. Sandeep Bhosale

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MDMatthew C. Deen
Matthew C. Deen
YZYanping Zhu
Yanping Zhu
CGChristina Gros
Christina Gros
NNNa Na
Na Na
PGPierre-André Gilormini
Pierre-André Gilormini
DVDavid J. Vocadlo
David J. Vocadlo
Loss of activity of the lysosomal glycosidase β-glucocerebrosidase (GCase) causes the lysosomal storage disease Gaucher disease (GD) and has emerged as the greatest genetic risk factor for the development of both Parkinson disease (PD) and dementia with Lewy bodies. There is significant interest into how GCase dysfunction contributes to these diseases, however, progress toward a full understanding is complicated by presence of endogenous cellular factors that influence lysosomal GCase activity. Indeed, such factors are thought to contribute to the high degree of variable penetrance of GBA mutations among patients. Robust methods to quantitatively measure GCase activity within lysosomes are therefore needed to advance research in this area, as well as to develop clinical assays to monitor disease progression and assess GCase-directed therapeutics. Here, we report a selective fluorescence-quenched substrate, LysoFQ-GBA, which enables measuring endogenous levels of lysosomal GCase activity within living cells. LysoFQ-GBA is a sensitive tool for studying chemical or genetic perturbations of GCase activity using either fluorescence microscopy or flow cytometry. We validate the quantitative nature of measurements made with LysoFQ-GBA using various cell types and demonstrate that it accurately reports on both target engagement by GCase inhibitors and the GBA allele status of cells. Furthermore, through comparisons of GD, PD, and control patient-derived tissues, we show there is a close correlation in the lysosomal GCase activity within monocytes, neuronal progenitor cells, and neurons. Accordingly, analysis of clinical blood samples using LysoFQ-GBA may provide a surrogate marker of lysosomal GCase activity in neuronal tissue.

16 November 2022 in ACS Catalysis
Verified
Journal Article
Closed access
OAOluwafemi Akintola
Oluwafemi Akintola
MFMarco Farren-Dai
Marco Farren-Dai
WRWeiwu Ren
Weiwu Ren
SBSandeep Bhosale
Sandeep Bhosale
RBRobert Britton
Robert Britton
ABAndrew James Bennet
Andrew James Bennet

20 September 2024 in ACS Catalysis
Verified
Journal Article
Open access
SBSandeep Bhosale
Sandeep Bhosale
SKSachin Kandalkar
Sachin Kandalkar
PGPierre-André Gilormini
Pierre-André Gilormini
OAOluwafemi Akintola
Oluwafemi Akintola
RRRhianna Rowland
Rhianna Rowland
ABAndrew James Bennet
Andrew James Bennet
Mutations in many members of the set of human lysosomal glycoside hydrolases cause a wide range of lysosomal storage diseases. As a result, much effort has been directed toward identifying pharmacological chaperones of these lysosomal enzymes. The majority of the candidate chaperones are active site-directed competitive iminosugar inhibitors but these have met with limited success. As a first step toward an alternative class of pharmacological chaperones we explored the potential of small molecule mechanism-based reversible covalent inhibitors to form transient enzyme–inhibitor adducts. By serial synthesis and kinetic analysis of candidate molecules, we show that rational tuning of the chemical reactivity of glucose-configured carbasugars delivers cyclohexenyl-based allylic carbasugar that react with the lysosomal enzyme β-glucocerebrosidase (GCase) to form covalent enzyme-adducts with different half-lives. X-ray structural analysis of these compounds bound noncovalently to GCase, along with the structures of the covalent adducts of compounds that reacted with the catalytic nucleophile of GCase, reveal unexpected reactivities of these compounds. Using differential scanning fluorimetry, we show that formation of a transient covalent intermediate stabilizes the folded enzyme against thermal denaturation. In addition, these covalent adducts break down to liberate the active enzyme and a product that is no longer inhibitory. We further show that the one compound, which reacts through an unprecedented SN1′-like mechanism, exhibits exceptional reactivity–illustrated by this compound also covalently labeling an α-glucosidase. We anticipate that such carbasugar-based single turnover covalent ligands may serve as pharmacological chaperones for lysosomal glycoside hydrolases and other disease-associated retaining glycosidases. The unusual reactivity of these molecules should also open the door to creation of new chemical biology probes to explore the biology of this important superfamily of glycoside hydrolases.

2 August 2023 in ACS Chemical Biology
Verified
Journal Article
Closed access
SBSandeep Bhosale
Sandeep Bhosale
MDMatthew C. Deen
Matthew C. Deen
CPCameron Proceviat
Cameron Proceviat
AHAndrew Hettle
Andrew Hettle
DWDana K. Winter
Dana K. Winter
DVDavid J. Vocadlo
David J. Vocadlo

14 October 2024 in Molecules
Verified
Journal Article
Open access
PDF file
OAOluwafemi Akintola
Oluwafemi Akintola
SBSandeep Bhosale
Sandeep Bhosale
ABAndrew James Bennet
Andrew James Bennet
Glycoside hydrolases have been implicated in a wide range of human conditions including lysosomal storage diseases. Consequently, many researchers have directed their efforts towards identifying new classes of glycoside hydrolase inhibitors, both synthetic and from natural sources. A large percentage of such inhibitors are reversible competitive inhibitors that bind in the active site often due to them possessing structural features, often a protonatable basic nitrogen atom, that mimic the enzymatic transition state. We report that mechanism-based small molecule galacto-like configured cyclohexenyl carbasugars form reversible covalent complexes with both α-galactosidase and β-galactosidase. In addition, we show that the β-galactosidase from Aspergillus oryzae reacts with three different carbasugar inhibitors, with three different second-order rate constants (kinact/Ki), to give the same enzyme–carbasugar covalent intermediate. The surprising observation that the α-galacto-configured inhibitor covalently labels the A. oryzae β-galactosidase highlights the catalytic versatility of glycoside hydrolases. We expect that cyclohexenyl covalent inhibitors will become an important class of compounds in the chemical biologist’s tool box.

29 March 2022 in SAE International Journal of Advances and Current Practices in Mobility
Verified
Conference Paper
Closed access
KMKapil Mestry
Kapil Mestry
PMPratik Mahajan
Pratik Mahajan
HJHarshavardhini Jagadale
Harshavardhini Jagadale
SBSandeep Bhosale
Sandeep Bhosale
DGDeepak Gundecha
Deepak Gundecha
MKManas Koner
Manas Koner
The valve train is one of the most important part of engine , and its function is fresh charge inlet and exhaust exit according to order of engine based on intake and exhaust valve [1].The compression relief brake mechanism is one of the integrated brake technologies in Internal Combustion Engines (ICE) which not only reduces engine speed during downhill under overspeed condition by opening of one of the exhaust valves before the power stroke but also helpful to reduce brake pad wear by assisting in vehicle braking. The clearance between exhaust valve and piston during compression relief brake event is important aspect for overall valve train dynamic perspective. Valve motion study included this valve to piston clearance measurement in engine testing as mandate during product development phase. Looking at new products in future and to improve system level valve train dynamics in integrated brake design hardware, it is required to validate the design changes, a valve lift experimental test was performed to understand valve train dynamics during engine running condition. This valve motion measurement study has been performed for the first time for mid-range diesel engines in Cummins Technical Center India (CTCI).The displacement sensors were used for valve lift measurement. Special instrumentation was done on the valve cover to integrate sensor setup. Also, modification was done in exhaust valve spring retainers to incorporate displacement sensors for data acquisition. Steady state measurement data was taken for 50 cycles at various engine operating conditions such as motoring and firing. Peak Cylinder Pressure (PCP) sensor was installed in one cylinder and valve displacement data was acquired in the angle domain. Piston Profile was measured offline with 5-degree resolution in static condition.Upon test completion, all recorded valve displacement data was compared graphically with piston profile to evaluate valve to piston clearances for final validation. Also, there was no contact observed between valve and piston considering compression relief brake event for all Rotation Per Minute (RPM) data captured for firing and motoring conditions. Results are satisfactorily meeting the requirements. Post teardown of engine, all the valves and piston contact regions were found free from any kind of contact marks thereby validating the valve motion study.